期刊文献+

混胺(NH_3/CH_3NH_2)草酸根合铂(Ⅱ)混配配合物对人体癌细胞的作用及机制

Effect on the human cancer cells and anticancer mechanism of platinum(Ⅱ) complex of ammine/amine(NH_3/CH_3NH_2) with oxalate
下载PDF
导出
摘要 采用MTT和SRB法研究了混胺(NH3/CH3NH2)草酸根合铂(Ⅱ)混配配合物(MAOX)对人体癌细胞的增殖抑制作用,又通过流式细胞法、Giemsa染色法、等离子体质谱法研究了它的抗癌机制.实验结果表明:在10μmol.L-1浓度下,该配合物对HL-60和EJ两种细胞有较高的活性,其抑制率分别为51.35%和45.86%;它能阻止HL-60细胞G2+M→G1期的进行,造成G2+M期细胞的堆积;对HL-60细胞的凋亡诱导作用不明显;在相同浓度情况下其与HL-60细胞的DNA键合量大于顺铂. The antitumor activity of platinum(Ⅱ) complex of ammine/aminc (NH3/CH3NH2) with oxalate was determined by MTT and SRB methods in vitro, At the same time, the anticancer mechanism was studied by flow cytometry, Giemsa and Icp-Ms. The experimental results indicated that the complex had fairly higher activity against HI. 60 and EJ, and the inhibition rate was 51.35 and 45.86% at concentration of 10 μmol·L^-1 , respectively. The cell cycle was arrested on the G2+M→G1 , the effect of the complex on apoptosis was not obvious, and the level of total platinum bound to DNA was higher than that of cisplatin under the same conditions.
出处 《浙江大学学报(理学版)》 CAS CSCD 北大核心 2006年第2期200-203,208,共5页 Journal of Zhejiang University(Science Edition)
基金 浙江省自然科学基金资助项目(298068) 北京大学医学部天然药物及仿生药物国家重点实验室资助项目
关键词 混胺铂配合物 抗肿瘤活性 细胞周期 凋亡 DNA mixed ammine/amine platinum eomplexes antitumor activity cell cycle apoptosis DNA
  • 相关文献

参考文献14

  • 1YEE-PING H,STEVE C F A-Y,KENNETH K W T.Platinum-based anticancer agents:innovative design strategies and biological perspectives[J].Med Res Rev,2003,23(5):633-655.
  • 2ERNEST W,CHHRISTEN M G.Current status of platinum-based antitumor drugs[J].Chem Rev,1999,99:2451-2466.
  • 3KELLAND L R,MURRER B A,ABEL G,et al.Ammine/amine platinum (Ⅳ) dicarboxylates:a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines[J].Cancer Res,1992,52 (4):822-828.
  • 4YOSHIDA M,KHOKHAR A R,SIDDIK Z H.Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamineplatinum(Ⅳ) complexes in tumor cells resistant to cisdiamminedichloroplatinum(Ⅱ) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum (Ⅳ)[J].Cancer Res,1994,54(17):4691-4697.
  • 5ORR R M,O'NEILL C F,NICOLSON M C,et al.Evaluation of novel ammine/amine platinum (Ⅳ) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin,tetraplatin or carboplatin[J].Br J Cancer,1994,70(3):415-420.
  • 6LOH S Y,MISTRY P,KELLAND L R,et al.Reduced drug accumulation as a major mechanism of acquired reisitance to cisplatin in a human ovarian carcinoma cell line:circumvention studies using novel platinum(Ⅱ) and (Ⅳ) ammine/amine complexes[J].Br J Cancer,1992,66(6):1109-1115.
  • 7KHOKHAR A R,DENG Y,AL-BAKER S,et al.Synthesis and antitumor activity of ammine/amine platinum(Ⅱ) and (Ⅳ) complexes[J].J Inorg Biochem,1993,51(3):677-687.
  • 8ZHANG J C,GONG Y Q,ZHENG X M.Synthesis,characterization and antitumor activity of platinum(Ⅱ)complexes of mixed ammine/amine with bidentate carboxylates[J].Synth React Inorg Met-Org Chem,2002,32(1):49-55.
  • 9MOSMANN T R.Rapid colorimetric assay for cellular growth survival:application to proliferation and cytotoxicity assays[J].J Immunol Methods,1983,65 (1-2):55-63.
  • 10FRICKER S P.The application of sulforhodamine B as a colormetric endpoint in a cyotoxicity assay[J].Toxic In Vitro,1994,8(4):821-822.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部